AU3611000A - Thiazoloindolinone compounds - Google Patents

Thiazoloindolinone compounds Download PDF

Info

Publication number
AU3611000A
AU3611000A AU36110/00A AU3611000A AU3611000A AU 3611000 A AU3611000 A AU 3611000A AU 36110/00 A AU36110/00 A AU 36110/00A AU 3611000 A AU3611000 A AU 3611000A AU 3611000 A AU3611000 A AU 3611000A
Authority
AU
Australia
Prior art keywords
compound
thiazolindolinone
methyl
thiazolo
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36110/00A
Other languages
English (en)
Inventor
Ambrish Vyas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU3611000A publication Critical patent/AU3611000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
AU36110/00A 1999-03-04 2000-03-01 Thiazoloindolinone compounds Abandoned AU3611000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9904930.6A GB9904930D0 (en) 1999-03-04 1999-03-04 Thiazoloindolinone compounds
GB9904930 1999-03-04
PCT/US2000/005192 WO2000052013A2 (en) 1999-03-04 2000-03-01 Thiazoloindolinone compounds

Publications (1)

Publication Number Publication Date
AU3611000A true AU3611000A (en) 2000-09-21

Family

ID=10848912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36110/00A Abandoned AU3611000A (en) 1999-03-04 2000-03-01 Thiazoloindolinone compounds

Country Status (18)

Country Link
EP (1) EP1159280A2 (xx)
JP (1) JP2003532620A (xx)
KR (1) KR20020005606A (xx)
CN (1) CN1355807A (xx)
AU (1) AU3611000A (xx)
BR (1) BR0008677A (xx)
CA (1) CA2361580A1 (xx)
CZ (1) CZ20013187A3 (xx)
GB (1) GB9904930D0 (xx)
HK (1) HK1041692A1 (xx)
HU (1) HUP0200376A3 (xx)
IL (1) IL144808A0 (xx)
MX (1) MXPA01008910A (xx)
NO (1) NO20014262L (xx)
PL (1) PL351476A1 (xx)
TR (1) TR200102557T2 (xx)
WO (1) WO2000052013A2 (xx)
ZA (1) ZA200106826B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
WO2006060614A1 (en) * 2004-12-01 2006-06-08 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Methods for preparing pimecrolimus
UA103319C2 (xx) * 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Сполуки бензенсульфонамідтіазолу та -оксазолу$соединения бензенсульфонамидтиазола и -оксазола
JP4761000B1 (ja) * 2010-11-08 2011-08-31 小野薬品工業株式会社 手足症候群の予防および/または治療剤
WO2011125763A1 (ja) 2010-03-31 2011-10-13 小野薬品工業株式会社 手足症候群の予防および/または治療剤
CN111601617A (zh) 2017-12-13 2020-08-28 上海岸阔医药科技有限公司 一种用于预防或治疗与egfr 被抑制相关疾病的方法
CN111989095A (zh) 2018-04-16 2020-11-24 上海岸阔医药科技有限公司 预防或治疗肿瘤疗法副作用的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511852A (ja) * 1997-05-07 2002-04-16 スージェン・インコーポレーテッド 蛋白質キナーゼ活性の調節剤としての2−インドリノン誘導体
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
GB9904930D0 (en) 1999-04-28
IL144808A0 (en) 2002-06-30
BR0008677A (pt) 2002-01-08
WO2000052013A2 (en) 2000-09-08
PL351476A1 (en) 2003-04-22
EP1159280A2 (en) 2001-12-05
TR200102557T2 (tr) 2007-01-22
KR20020005606A (ko) 2002-01-17
NO20014262L (no) 2001-10-30
WO2000052013A3 (en) 2000-12-28
CN1355807A (zh) 2002-06-26
CA2361580A1 (en) 2000-09-08
HUP0200376A2 (en) 2002-06-29
NO20014262D0 (no) 2001-09-03
MXPA01008910A (es) 2002-03-27
HK1041692A1 (zh) 2002-07-19
HUP0200376A3 (en) 2003-07-28
CZ20013187A3 (cs) 2002-02-13
ZA200106826B (en) 2003-02-25
JP2003532620A (ja) 2003-11-05

Similar Documents

Publication Publication Date Title
ES2199156T3 (es) Derivados de aza-oxindol sustituidos.
EP1732920B1 (en) Thiophene derivatives as chk 1 inhibitors
AU781028B2 (en) Imidazo (1,3,5) triazinones and the use thereof
US7538113B2 (en) 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
CZ139097A3 (cs) 6-Arylpyrido[2,3-d]pyrimidiny a naftyridiny a farmaceutické prostředky na jejich bázi
EP2522670A1 (en) Heterocyclic CRF receptor antagonists
US20040180897A1 (en) Novel tyrosine kinase inhibitors
US6624171B1 (en) Substituted aza-oxindole derivatives
AU2012240026A1 (en) Methods and compositions for treating neurodegenerative diseases
PL165502B1 (pl) Sposób wytwarzania nowych pochodnych aminopirymidyny PL PL PL PL PL
CA2674875A1 (en) Purine derivatives
JP6797923B2 (ja) Alkおよびsrpk阻害剤ならびに使用方法
EP1325009B1 (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
CA3122623A1 (en) Halo-allylamine compounds and use thereof
WO2004016605A1 (en) 2-aminopyrimidine derivatives as adenosine a1 and a2a receptor antagonists
US6683081B2 (en) Triazolotriazinones and the use thereof
KR20010006509A (ko) 5,7-이치환된 4-아미노피리도[2,3-d]피리미딘 화합물 및 아데노신 키나제 억제제로서의 이의 용도
AU3611000A (en) Thiazoloindolinone compounds
US6492398B1 (en) Thiazoloindolinone compounds
CA2438113A1 (en) 2-alkoxyphenyl substituted imidazotriazinones
CN115160321A (zh) 一种伐地那非类似物及其合成方法和应用
CN113004305A (zh) 大环化合物及其制备方法和用途
CN113004284B (zh) 作为血浆激肽释放酶抑制剂的四环类化合物及其用途
WO2021168341A1 (en) Solid forms of 1-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-n,n-dimethylmethanamine
KR100282153B1 (ko) 3-알킬피롤록3,2-씨퀴놀린유도체

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted